ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers

NCT04236219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: ALLN-346
DRUG: Placebo

Sponsor

Allena Pharmaceuticals